Northpond Ventures III, LP 13D and 13G filings for Kyverna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 6:51 pm Purchase | 2025-12-31 | 13G | KYVERNA THERAPEUTICS INC KYTX | Northpond Ventures III, LP | 3,466,826 6.100% | 211,400 (+6.49%) | Filing |
| 2024-02-22 4:29 pm Purchase | 2024-02-12 | 13G | KYVERNA THERAPEUTICS INC KYTX | Northpond Ventures III, LP | 3,255,426 7.600% | 3,255,426 (New Position) | Filing |